EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rethinking pharmaceutical corruption in the age of ghost management: a broader approach to combating corruption

Marc-Andre Gagnon, Blue Miaoran Dong

Journal of Pharmaceutical Health Services Research · 01.07.2026 · 17 (3)

DOI: 10.1093/jphsr/rmag016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical Health Services Research, online erschienen am 15.07.2026. Verfasst von Marc-Andre Gagnon und 1 weiteren Autor:innen. Die Arbeit nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Social Sciences and Humanities Research Council.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The pharmaceutical industry operates within a complex and highly regulated environment, where even minor technical or regulatory decisions related to safety, effectiveness, intellectual property, and reimbursement can shift billions of dollars in revenue. Given the financial stakes, various questionable corporate strategies and corrupt practices are deployed to influence regulatory processes or prescribing behaviors, ultimately prioritizing profit over public health. However, actions that compromise the public interest and distort medical knowledge—such as shaping public policy to benefit private pharmaceutical corporations—are often excluded from narrow definitions of corruption. This study introduces a broader concept of corruption to better analyse the behind-the-scenes dynamics in the sector and identifies the principal modes of capture mechanism in the pharmaceutical sector, the main fields in which these strategies are applied, and explores the main priorities for combating corruption. The well-being of patients and the improvement of health outcomes should remain paramount in shaping the pharmaceutical sector through public policy.

Förderung

  • Social Sciences and Humanities Research Council

Zitieren

APA

Gagnon, M., & Dong, B. M. (2026). Rethinking pharmaceutical corruption in the age of ghost management: a broader approach to combating corruption. Journal of Pharmaceutical Health Services Research, 17(3). https://doi.org/10.1093/jphsr/rmag016

Vancouver

Gagnon M, Dong BM. Rethinking pharmaceutical corruption in the age of ghost management: a broader approach to combating corruption. Journal of Pharmaceutical Health Services Research. 2026;17(3). doi:10.1093/jphsr/rmag016

BibTeX
@article{Gagnon2026,
  author = {Gagnon, Marc-Andre and Dong, Blue Miaoran},
  title = {Rethinking pharmaceutical corruption in the age of ghost management: a broader approach to combating corruption},
  journal = {Journal of Pharmaceutical Health Services Research},
  year = {2026},
  volume = {17},
  number = {3},
  doi = {10.1093/jphsr/rmag016}
}
Kostenlos starten →